Literature DB >> 2485912

Late anaplastic gliomas in children previously treated for acute lymphoblastic leukemia.

S Shapiro1, J Mealey.   

Abstract

At least 33 cases of late anaplastic gliomas in children previously treated for acute lymphoblastic leukemia have been discussed in the literature including 20 well-documented cases. The frequency of this second malignancy is much greater than expected and may represent a 'new syndrome' with some genetic predisposition. Additionally, CNS prophylaxis which includes both radiation and intrathecal methotrexate appears to work synergistically in increasing the incidence of glial tumors especially multifocal tumors in these patients. The prognosis for these children is dismal but an aggressive treatment approach including surgery, interstitial radiation, and chemotherapy appears to improve survival.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2485912     DOI: 10.1159/000120465

Source DB:  PubMed          Journal:  Pediatr Neurosci        ISSN: 0255-7975


  5 in total

Review 1.  Environmental risk factors for primary malignant brain tumors: a review.

Authors:  M Wrensch; M L Bondy; J Wiencke; M Yost
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

2.  Therapy-associated secondary tumors in patients with non-germinomatous malignant germ cell tumors.

Authors:  Hideo Nakamura; Keishi Makino; Yukitaka Ushio; Ryoichi Arima; Jun-ichi Kuratsu
Journal:  J Neurooncol       Date:  2011-05-01       Impact factor: 4.130

3.  Response to chemotherapy of a radiation-induced glioblastoma multiforme.

Authors:  Linda Nicolardi; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

4.  Radio-induced gliomas: 20-year experience and critical review of the pathology.

Authors:  Maurizio Salvati; Alessandro D'Elia; Graziella Angelina Melone; Christian Brogna; Alessandro Frati; Antonino Raco; Roberto Delfini
Journal:  J Neurooncol       Date:  2008-06-20       Impact factor: 4.130

5.  Individualized automated planning for dose bath reduction in robotic radiosurgery for benign tumors.

Authors:  Linda Rossi; Alejandra Méndez Romero; Maaike Milder; Erik de Klerck; Sebastiaan Breedveld; Ben Heijmen
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.